terazosin

Generic: terazosin hydrochloride

Labeler: proficient rx lp
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin hydrochloride
Labeler proficient rx lp
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 10 mg/1

Manufacturer
Proficient Rx LP

Identifiers & Regulatory

Product NDC 63187-620
Product ID 63187-620_4b095509-2a35-488c-a8d5-f5834be0d31f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075317
Listing Expiration 2026-12-31
Marketing Start 2004-12-21

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63187620
Hyphenated Format 63187-620

Supplemental Identifiers

RxCUI
260376
UPC
0363187620301
UNII
D32S14F082

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin hydrochloride (source: ndc)
Application Number ANDA075317 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (63187-620-30)
  • 60 CAPSULE in 1 BOTTLE (63187-620-60)
  • 90 CAPSULE in 1 BOTTLE (63187-620-90)
source: ndc

Packages (3)

63187-620-30 30 CAPSULE in 1 BOTTLE (63187-620-30) 63187-620-60 60 CAPSULE in 1 BOTTLE (63187-620-60) 63187-620-90 90 CAPSULE in 1 BOTTLE (63187-620-90)

Ingredients (1)

terazosin hydrochloride (10 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4b095509-2a35-488c-a8d5-f5834be0d31f", "openfda": {"upc": ["0363187620301"], "unii": ["D32S14F082"], "rxcui": ["260376"], "spl_set_id": ["27f8952a-189d-4687-854e-c51da619bf3d"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (63187-620-30)", "package_ndc": "63187-620-30", "marketing_start_date": "20181201"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (63187-620-60)", "package_ndc": "63187-620-60", "marketing_start_date": "20181201"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (63187-620-90)", "package_ndc": "63187-620-90", "marketing_start_date": "20181201"}], "brand_name": "Terazosin", "product_id": "63187-620_4b095509-2a35-488c-a8d5-f5834be0d31f", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "63187-620", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20041221", "listing_expiration_date": "20261231"}